Chemicals - Specialty
Compare Stocks
2 / 10Stock Comparison
GEVO vs LIN
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
GEVO vs LIN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $493M | $228.85B |
| Revenue (TTM) | $174M | $34.66B |
| Net Income (TTM) | $-11M | $7.13B |
| Gross Margin | 23.4% | 46.0% |
| Operating Margin | -4.6% | 28.8% |
| Forward P/E | — | 27.7x |
| Total Debt | $168M | $26.99B |
| Cash & Equiv. | $1M | $5.06B |
GEVO vs LIN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Gevo, Inc. (GEVO) | 100 | 157.4 | +57.4% |
| Linde plc (LIN) | 100 | 244.1 | +144.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GEVO vs LIN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GEVO is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 8.5%, EPS growth 58.8%, 3Y rev CAGR 415.1%
- Lower volatility, beta 1.64, Low D/E 35.6%, current ratio 1.82x
- 8.5% revenue growth vs LIN's 3.0%
LIN carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 6 yrs, beta 0.24, yield 1.2%
- 375.2% 10Y total return vs GEVO's -98.6%
- Beta 0.24, yield 1.2%, current ratio 0.88x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.5% revenue growth vs LIN's 3.0% | |
| Quality / Margins | 20.6% margin vs GEVO's -6.6% | |
| Stability / Safety | Beta 0.24 vs GEVO's 1.64 | |
| Dividends | 1.2% yield; 6-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +88.0% vs LIN's +11.2% | |
| Efficiency (ROA) | 8.3% ROA vs GEVO's -1.7%, ROIC 11.3% vs -2.8% |
GEVO vs LIN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
GEVO vs LIN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
LIN leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LIN is the larger business by revenue, generating $34.7B annually — 198.7x GEVO's $174M. LIN is the more profitable business, keeping 20.6% of every revenue dollar as net income compared to GEVO's -6.6%. On growth, GEVO holds the edge at +47.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $174M | $34.7B |
| EBITDAEarnings before interest/tax | $18M | $12.1B |
| Net IncomeAfter-tax profit | -$11M | $7.1B |
| Free Cash FlowCash after capex | -$35M | $5.1B |
| Gross MarginGross profit ÷ Revenue | +23.4% | +46.0% |
| Operating MarginEBIT ÷ Revenue | -4.6% | +28.8% |
| Net MarginNet income ÷ Revenue | -6.6% | +20.6% |
| FCF MarginFCF ÷ Revenue | -19.9% | +14.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +47.5% | +8.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +3.8% | +13.4% |
Valuation Metrics
GEVO leads this category, winning 3 of 4 comparable metrics.
Valuation Metrics
On an enterprise value basis, LIN's 19.7x EV/EBITDA is more attractive than GEVO's 102.1x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $493M | $228.8B |
| Enterprise ValueMkt cap + debt − cash | $659M | $250.8B |
| Trailing P/EPrice ÷ TTM EPS | -14.50x | 33.85x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 27.67x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.33x |
| EV / EBITDAEnterprise value multiple | 102.12x | 19.75x |
| Price / SalesMarket cap ÷ Revenue | 3.07x | 6.73x |
| Price / BookPrice ÷ Book value/share | 1.01x | 5.82x |
| Price / FCFMarket cap ÷ FCF | — | 44.97x |
Profitability & Efficiency
LIN leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
LIN delivers a 17.8% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $-2 for GEVO. GEVO carries lower financial leverage with a 0.36x debt-to-equity ratio, signaling a more conservative balance sheet compared to LIN's 0.68x. On the Piotroski fundamental quality scale (0–9), LIN scores 6/9 vs GEVO's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -2.4% | +17.8% |
| ROA (TTM)Return on assets | -1.7% | +8.3% |
| ROICReturn on invested capital | -2.8% | +11.3% |
| ROCEReturn on capital employed | -3.1% | +13.0% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 |
| Debt / EquityFinancial leverage | 0.36x | 0.68x |
| Net DebtTotal debt minus cash | $166M | $21.9B |
| Cash & Equiv.Liquid assets | $1M | $5.1B |
| Total DebtShort + long-term debt | $168M | $27.0B |
| Interest CoverageEBIT ÷ Interest expense | -0.04x | 34.52x |
Total Returns (Dividends Reinvested)
Evenly matched — GEVO and LIN each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LIN five years ago would be worth $17,394 today (with dividends reinvested), compared to $3,476 for GEVO. Over the past 12 months, GEVO leads with a +88.0% total return vs LIN's +11.2%. The 3-year compound annual growth rate (CAGR) favors GEVO at 18.2% vs LIN's 11.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -1.5% | +15.5% |
| 1-Year ReturnPast 12 months | +88.0% | +11.2% |
| 3-Year ReturnCumulative with dividends | +65.0% | +39.7% |
| 5-Year ReturnCumulative with dividends | -65.2% | +73.9% |
| 10-Year ReturnCumulative with dividends | -98.6% | +375.2% |
| CAGR (3Y)Annualised 3-year return | +18.2% | +11.8% |
Risk & Volatility
LIN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
LIN is the less volatile stock with a 0.24 beta — it tends to amplify market swings less than GEVO's 1.64 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LIN currently trades 94.7% from its 52-week high vs GEVO's 68.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.64x | 0.24x |
| 52-Week HighHighest price in past year | $2.97 | $521.28 |
| 52-Week LowLowest price in past year | $1.01 | $387.78 |
| % of 52W HighCurrent price vs 52-week peak | +68.4% | +94.7% |
| RSI (14)Momentum oscillator 0–100 | 53.5 | 51.7 |
| Avg Volume (50D)Average daily shares traded | 4.5M | 2.3M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates GEVO as "Buy" and LIN as "Buy". Consensus price targets imply 72.4% upside for GEVO (target: $4) vs 9.3% for LIN (target: $540). LIN is the only dividend payer here at 1.21% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $3.50 | $539.71 |
| # AnalystsCovering analysts | 14 | 28 |
| Dividend YieldAnnual dividend ÷ price | — | +1.2% |
| Dividend StreakConsecutive years of raises | — | 6 |
| Dividend / ShareAnnual DPS | — | $6.00 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.0% |
LIN leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). GEVO leads in 1 (Valuation Metrics). 1 tied.
GEVO vs LIN: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is GEVO or LIN a better buy right now?
For growth investors, Gevo, Inc.
(GEVO) is the stronger pick with 849. 3% revenue growth year-over-year, versus 3. 0% for Linde plc (LIN). Linde plc (LIN) offers the better valuation at 33. 8x trailing P/E (27. 7x forward), making it the more compelling value choice. Analysts rate Gevo, Inc. (GEVO) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — GEVO or LIN?
Over the past 5 years, Linde plc (LIN) delivered a total return of +73.
9%, compared to -65. 2% for Gevo, Inc. (GEVO). Over 10 years, the gap is even starker: LIN returned +375. 2% versus GEVO's -98. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — GEVO or LIN?
By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.
24β versus Gevo, Inc. 's 1. 64β — meaning GEVO is approximately 584% more volatile than LIN relative to the S&P 500. On balance sheet safety, Gevo, Inc. (GEVO) carries a lower debt/equity ratio of 36% versus 68% for Linde plc — giving it more financial flexibility in a downturn.
04Which is growing faster — GEVO or LIN?
By revenue growth (latest reported year), Gevo, Inc.
(GEVO) is pulling ahead at 849. 3% versus 3. 0% for Linde plc (LIN). On earnings-per-share growth, the picture is similar: Gevo, Inc. grew EPS 58. 8% year-over-year, compared to 7. 1% for Linde plc. Over a 3-year CAGR, GEVO leads at 415. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — GEVO or LIN?
Linde plc (LIN) is the more profitable company, earning 20.
3% net margin versus -21. 1% for Gevo, Inc. — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIN leads at 26. 3% versus -11. 7% for GEVO. At the gross margin level — before operating expenses — LIN leads at 43. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is GEVO or LIN more undervalued right now?
Analyst consensus price targets imply the most upside for GEVO: 72.
4% to $3. 50.
07Which pays a better dividend — GEVO or LIN?
In this comparison, LIN (1.
2% yield) pays a dividend. GEVO does not pay a meaningful dividend and should not be held primarily for income.
08Is GEVO or LIN better for a retirement portfolio?
For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
24), 1. 2% yield, +375. 2% 10Y return). Gevo, Inc. (GEVO) carries a higher beta of 1. 64 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LIN: +375. 2%, GEVO: -98. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between GEVO and LIN?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: GEVO is a small-cap high-growth stock; LIN is a large-cap quality compounder stock. LIN pays a dividend while GEVO does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.